INZY - Inozyme Pharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Inozyme Pharma's activity chart (see below) currently has 46 price targets and 53 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 19.05% of the time, taking 9.29 days on average.

Most recent stock forecast was given by TIAGO FAUTH from RAYMOND JAMES on 19-May-2025. First documented stock forecast 18-Aug-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 19-May-2025

$4

$9

1 years 6 months 3 days ago
(19-May-2025)

1/3 (33.33%)

$0.01 (0.25%)

38

Buy Since 29-Nov-2021

$12

1 years 6 months 6 days ago
(16-May-2025)

0/12 (0%)

$8.05 (203.80%)

Buy Since 07-Feb-2022

1 years 7 months 12 days ago
(10-Apr-2025)

0/9 (0%)

$9.77 (230.97%)

Buy Since 18-Aug-2020

$7

$15

1 years 8 months 12 days ago
(10-Mar-2025)

0/7 (0%)

$5.94 (560.38%)

Buy Since 04-May-2021

$40

1 years 10 months 9 days ago
(13-Jan-2025)

0/2 (0%)

$34.55 (633.94%)

Show more analysts

Please expand the browser size to see the chart

What is INZY (Inozyme Pharma) average time for price targets to be met?

On average it took 9 days for the stock forecasts to be reached, with an average price target met ratio of 19.05%.

Which analyst most recently updated their price target on INZY (Inozyme Pharma)?

Tiago Fauth

Which analyst has the lowest performance score on INZY (Inozyme Pharma) with a proven track record?

TIAGO FAUTH

Which analyst has the most public recommendations on INZY (Inozyme Pharma)?

Tiago Fauth works at RAYMOND JAMES and has 6 price targets and 4 ratings on INZY

Which analyst is the currently most bullish on INZY (Inozyme Pharma)?

Tazeen Ahmad with the highest potential upside of $10

Which analyst is the currently most reserved on INZY (Inozyme Pharma)?

Tiago Fauth with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?